FDA 483 - Bristol-Myers Squibb Company - June 16, 2023
FDA 483 for Bristol-Myers Squibb Company on June 16, 2023. Product: biologics. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for Bristol-Myers Squibb Company on June 16, 2023. Product: biologics. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Bristol-Myers Squibb CompanyInspection Date
June 16, 2023
Product Type
biologics
ID: 4ea843bb-7d44-433b-b1f8-807afaf7865e
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox